The Effect of Ultrasound-guided Compression Immediately After Transrectal Ultrasound-guided Prostate Biopsy on Postbiopsy Bleeding: a Randomized Controlled Pilot Study
Overview
Affiliations
Purpose: To evaluate whether ultrasound-guided compression performed immediately after transrectal ultrasound (TRUS)-guided prostate biopsy decreases bleeding complications.
Methods: We prospectively evaluated a total of 148 consecutive patients who underwent TRUS-guided prostate biopsy between March 2015 and July 2016. Systematic 12-core prostate biopsy was performed in all patients. Of these, 100 patients were randomly assigned to one of two groups: the compression group (n = 50) underwent TRUS-guided compression on bleeding biopsy tracts immediately after prostate biopsy, while the non-compression group (n = 50) underwent TRUS-guided prostate biopsy alone. The incidence rate and duration of hematuria, hematospermia, and rectal bleeding were compared between the two groups.
Results: The incidence rates of hematuria and hematospermia were not significantly different between the two groups (60 vs. 64%, p = 0.68; 22 vs. 30%, p = 0.362, respectively, for compression vs. non-compression group). The rectal bleeding incidence was significantly lower in the compression group as compared to the non-compression group (20 vs. 44%, p = 0.01). However, there were no significant differences in the median duration of hematuria, hematospermia, or rectal bleeding between the two groups (2, 8, and 2 days vs. 2, 10, and 1 days, p > 0.05, respectively, for compression vs. non-compression group). TRUS-guided compression [p = 0.004, odds ratio (OR) 0.25] and patient age (p = 0.013, OR 0.93) were significantly protective against the occurrence of rectal bleeding after prostate biopsy in multivariable analysis.
Conclusions: Although it has no impact on other complications, ultrasound-guided compression on bleeding biopsy tracts performed immediately after TRUS-guided prostate biopsy is an effective and practical method to treat or decrease rectal bleeding.
Jung J, Moon H, Kim J, Bae S, Han C, Park B Int Urol Nephrol. 2021; 53(12):2437-2443.
PMID: 34591227 DOI: 10.1007/s11255-021-03006-2.
Malik A, Ishtiaq R, Goraya M, Inayat F, Gaduputi V J Investig Med High Impact Case Rep. 2021; 9:23247096211013206.
PMID: 33969720 PMC: 8113366. DOI: 10.1177/23247096211013206.
Park J, Kim J, Bae S, Lee Y, Han C, Kang S Medicine (Baltimore). 2019; 98(20):e15623.
PMID: 31096472 PMC: 6531163. DOI: 10.1097/MD.0000000000015623.
Quinlan M, Bolton D, Casey R Can Urol Assoc J. 2017; 12(3):E146-E153.
PMID: 29283091 PMC: 5869041. DOI: 10.5489/cuaj.4660.